Inhibition of acetylcholinesterase in patients receiving irinotecan (camptothecin-11).
Tobin
Peter
P
Rivory
Laurent
L
Clarke
Stephen
S
D000110:Acetylcholinesterase / Q000097:blood; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000097:blood; D002166:Camptothecin / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000097:blood; D002800:Cholinesterase Inhibitors / Q000009:adverse effects*; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology; D006801:Humans; D000077146:Irinotecan
D000972:Antineoplastic Agents, Phytogenic; D002800:Cholinesterase Inhibitors; D000077146:Irinotecan; D000110:Acetylcholinesterase; D002166:Camptothecin